Health · 19 August 2026

Experimental mRNA drug stops skin cancer returning after surgery

Drugmakers Merck and Moderna announced on Wednesday that their personalised mRNA vaccine, intismeran, prevented melanoma from coming back or spreading. The experimental drug was given to over 1,000 patients who had surgery to remove their cancer, combined with another drug called Keytruda. Intismeran is a potentially significant step for people with melanoma, the deadliest form of skin cancer.

By BriefTea Editorial · 19 August 2026 at 22:57

Reported by Independent · How we write briefs

Get the app

Understand this story

What is Keytruda? What is melanoma? What is mRNA? Who makes these drugs?

More briefs

HealthCorrecting hearing loss can cut dementia risk by almost half HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care More health stories → Browse all stories →